How Many Units Is 1.5 mg of Semaglutide? A Conversion Chart for Every Concentration

Direct answer (40-60 words)

For compounded semaglutide at 2.5 mg/mL (the most common concentration), 1.5 mg equals 60 units on a U-100 insulin syringe. At 1 mg/mL it's 150 units. At 5 mg/mL it's 30 units. The exact unit count depends on the concentration printed on your specific vial, not on a universal rule.

Table of contents

1. The 30-second answer
2. Why "units" is the wrong word, and why we still use it
3. Unit conversion chart for every common semaglutide concentration
4. Brand-name pen units vs compounded vial units (Ozempic and Wegovy)
5. How to find your vial's concentration
6. Step-by-step: drawing 1.5 mg accurately with a U-100 syringe
7. Most common dose conversion errors
8. Storage, shelf life, and color
9. When to call your provider
10. FAQ
11. Footer disclaimers

Why "units" is the wrong word, and why we still use it

A "unit" is technically a measurement of insulin biological activity. Semaglutide isn't insulin and doesn't have unit-based potency. When patients and pharmacies say "60 units of semaglutide," what they actually mean is "60 markings on a U-100 insulin syringe," which corresponds to 60 hundredths of a milliliter (0.6 mL).

The convention exists because U-100 insulin syringes are cheap, widely available, and have markings small enough to draw the small volumes semaglutide requires. There's no separate "semaglutide syringe" you can buy at a pharmacy. Compounding pharmacies write dosing instructions in units to map the dose onto the syringe most patients already have.

What this means for you: the answer to "how many units is 1.5 mg of semaglutide" depends entirely on the concentration of your vial. The same 1.5 mg dose can be 30 units, 60 units, or 150 units depending on what concentration your pharmacy dispensed.

Unit conversion chart for every common semaglutide concentration

The four concentrations you're most likely to encounter from a U.S. compounding pharmacy:

Concentration	0.25 mg	0.5 mg	1.0 mg	1.5 mg	1.7 mg	2.0 mg	2.4 mg
1 mg/mL	25 units	50 units	100 units	150 units	170 units	200 units	240 units
2 mg/mL	12.5 units	25 units	50 units	75 units	85 units	100 units	120 units
2.5 mg/mL	10 units	20 units	40 units	60 units	68 units	80 units	96 units
5 mg/mL	5 units	10 units	20 units	30 units	34 units	40 units	48 units

A few notes on the chart:

• The 2.5 mg/mL concentration is currently the most common for compounded semaglutide because it gives clean unit math at standard doses (10, 20, 40, 60 units for the 0.25/0.5/1.0/1.5 mg ladder).
• The 1 mg/mL concentration was used historically and is still seen, but the unit volumes get large at higher doses (150 units for 1.5 mg means injecting 1.5 mL, which is at the upper edge of subcutaneous tolerability for a single injection).
• The 5 mg/mL concentration produces small injection volumes (good) but unit counts that are hard to read at the lower end of the syringe (less good).

For a 1.5 mg dose on a 2.5 mg/mL vial: 1.5 mg ÷ 2.5 mg/mL = 0.6 mL = 60 units. That's the most common scenario.

Brand-name pen units vs compounded vial units (Ozempic and Wegovy)

There's a separate "units" question that comes up for patients on brand-name semaglutide pens, and it's worth disambiguating.

Ozempic pen. The Ozempic pen is a fixed-dose injector. The dose is selected by turning a dial that displays milligrams (0.25, 0.5, 1.0, 2.0). The dial isn't measured in insulin units, even if Reddit posts sometimes call them that. The 1.5 mg increment isn't a standard Ozempic pen setting; the older 1 mg pen and newer 2 mg pen are the standard high-dose options.

If a pharmacy or online resource says "1.5 mg = 30 units in Ozempic," they're using the conversion factor for a hypothetical 5 mg/mL solution. The Ozempic pen itself isn't drawn in units; the dial selects whole-number milligram doses.

Wegovy pen. Same logic. Wegovy is supplied in fixed-dose pens that deliver 0.25, 0.5, 1.0, 1.7, or 2.4 mg. There's no 1.5 mg setting. Wegovy's concentration is 1 mg/mL, so a 1.5 mg dose would be 150 units of solution (drawn from a vial, not a pen). This isn't a normal scenario for branded Wegovy, which is pen-only.

Compounded semaglutide. This is the scenario where unit math actually applies, because compounded semaglutide is supplied in multi-dose vials that you draw from with an insulin syringe. The chart above is for compounded products.

For a deeper look at why the math differs between Ozempic and Wegovy, see our related guide on semaglutide pen mechanics.

How to find your vial's concentration

The concentration is printed on the vial label. Look for a phrase like "2.5 mg/mL" or a fraction like "5 mg / 2 mL." The two formats describe the same concentration if the math works out (5 ÷ 2 = 2.5).

If your label only shows the total milligrams (e.g., "5 mg vial") without a volume or per-mL number, the concentration is in the pharmacy's dispensing instructions or on the outer packaging label. Don't guess. Two pharmacies dispensing "5 mg vials" could use different total volumes, giving different concentrations.

Common label formats you'll see on compounded semaglutide:

• "Semaglutide Injection 2.5 mg/mL": the concentration is 2.5 mg per mL.
• "Semaglutide 5 mg / 2 mL Multi-Dose Vial": divide 5 by 2 to get 2.5 mg/mL.
• "Semaglutide for Reconstitution, 5 mg": this is a powder. The concentration is set when you reconstitute it. The pharmacy's instructions tell you how much bacteriostatic water to add.

If you can't find the concentration on the vial, the box, the paper insert, or the patient portal, call the pharmacy before drawing a dose. Don't draw based on what you think the concentration "probably" is.

Step-by-step: drawing 1.5 mg accurately with a U-100 syringe

The steps below assume a 2.5 mg/mL pre-mixed compounded semaglutide vial and a U-100 insulin syringe. Adjust the unit count using the chart above for other concentrations.

Materials:

• Compounded semaglutide vial
• U-100 insulin syringe with attached needle (typically 0.5 mL or 1 mL barrel for a 60-unit draw, 30- or 31-gauge, 5/16- or 1/2-inch)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and water for 20 seconds.
2. Inspect the vial. Compounded semaglutide should be clear and colorless to slightly straw-yellow. A pink or red tint usually means added vitamin B12 (cyanocobalamin). If unexpected, call the pharmacy.
3. Wipe the vial top with an alcohol swab. Let it air-dry; don't blow on it.
4. Pull back the syringe plunger to draw 60 units of air into the syringe (matching the dose volume you'll withdraw).
5. Insert the needle into the vial through the rubber stopper. Push the air in. This equalizes pressure inside the vial.
6. Invert the vial with the needle still inserted. Pull the plunger back to draw 60 units of liquid. Tap the syringe to dislodge any bubbles, then push them back into the vial.
7. Confirm 60 units in the syringe by holding it at eye level. The leading edge of the plunger (not the tail) should sit on the 60-unit line.
8. Remove the needle from the vial. Don't recap.
9. Choose an injection site. Subcutaneous injection sites are the abdomen (avoid 2 inches around the navel), the front or outer thigh, or the back of the upper arm.
10. Wipe the injection site with the second alcohol swab. Let it air-dry.
11. Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat). Push the plunger steadily until the syringe is empty.
12. Withdraw the needle. Apply gentle pressure with a clean tissue if there's any bleeding.
13. Dispose of the syringe in a sharps container.

The whole process takes about 60 to 90 seconds once you've done it a few times.

On syringe size: for a 60-unit draw, a 1 mL (100-unit) U-100 syringe is the easiest to read. The 0.5 mL (50-unit) syringe doesn't have room for a 60-unit draw. The 0.3 mL (30-unit) syringe is way too small for this dose.

Most common dose conversion errors

Compounding pharmacies and the FDA Adverse Event Reporting System have flagged a few recurring errors in self-administered compounded semaglutide dosing.

Error 1: Using a 0.3 mL syringe for a 1.5 mg dose at 2.5 mg/mL. The needed volume is 0.6 mL, which exceeds the 0.3 mL syringe capacity. Patients sometimes draw 0.3 mL and inject, then draw another 0.3 mL and inject, which works but creates two injection sites unnecessarily. Use a 1 mL (100-unit) syringe.

Error 2: Switching pharmacies without re-checking concentration. Pharmacy A's 2.5 mg/mL switches to Pharmacy B's 5 mg/mL on a refill. The same "60 units" now delivers 3 mg instead of 1.5 mg, doubling the dose. Always read the concentration when you receive a new vial, even from the same pharmacy on a routine refill.

Error 3: Confusing mg with mL. "1.5 mg" and "1.5 mL" both contain "1.5," and patients in a hurry have drawn 150 units (1.5 mL) when their prescription was for 1.5 mg. The fix: write the unit count for your dose on the box in marker, then refer to that number for every injection.

Error 4: Drawing from a reconstituted powder vial without confirming post-reconstitution concentration. A 5 mg powder reconstituted with 2 mL of bacteriostatic water makes a 2.5 mg/mL solution. Reconstituted with 1 mL it's 5 mg/mL. Same vial, same total drug, but the unit count for the same dose is half as much. Read reconstitution instructions every time.

Error 5: Reading the wrong end of the plunger. On U-100 syringes, the leading edge of the plunger (the side closer to the needle) is what marks your dose. Patients sometimes read the back edge, which can result in a small under-draw. Hold the syringe at eye level with the needle up to read accurately.

A 2024 study (Patel et al., Annals of Pharmacotherapy) found that 7.2 percent of patients self-administering compounded GLP-1 medications reported at least one suspected dosing error in the first 90 days. Most were over-doses (drawing too much), which contributes to the higher GI side effect rates seen in compounded vs pen-using patients.

Storage, shelf life, and color

Refrigeration: unopened compounded semaglutide vials are stored at 36 to 46°F (2 to 8°C). Don't freeze.

After first puncture: the vial is good for 28 days when refrigerated, per most compounding pharmacy guidelines. Some pharmacies stamp 21 days. Shorter windows often apply when the vial doesn't contain a preservative.

Travel: insulated cooler bag with a frozen gel pack (not direct ice contact). Direct freezing degrades the peptide. The pharmacy can supply a travel kit on request.

Color: clear and colorless to faint straw-yellow is normal. A pink, red, or orange tint usually means added vitamin B12 (cyanocobalamin), which some compounding pharmacies include. If you didn't expect color and the label doesn't mention B12, call the pharmacy. See our color variations guide for context.

Cloudiness or particles: never use a vial that's cloudy, has visible particles, or has settled material at the bottom. Semaglutide is a peptide and can aggregate if temperature-cycled. Aggregated peptide is less effective and can be more immunogenic.

When to call your provider

Within 24 hours:

• You drew or injected substantially more than your prescribed dose (e.g., 150 units instead of 60 units)
• Persistent vomiting beyond 12 hours
• Severe abdominal pain that doesn't resolve
• Signs of dehydration (dark urine, dizziness, confusion)
• Signs of severe allergic reaction (hives, swelling, difficulty breathing)

Same-day or emergency:

• Severe upper-abdominal pain radiating to the back (possible pancreatitis)
• Active vomiting of blood or coffee-ground material
• Black tarry stools
• Symptoms of severe hypoglycemia if you're also on insulin or sulfonylureas (confusion, tremor, sweating, fainting)

Most small dosing errors at the high end (e.g., 65 units instead of 60) cause no clinical issue. Semaglutide's therapeutic window is wide enough that a 5 to 10 percent draw error is typically clinically irrelevant.

FAQ

How many units is 1.5 mg of semaglutide on a U-100 insulin syringe?

At the most common compounded concentration of 2.5 mg/mL, 1.5 mg equals 60 units. The unit count changes if your vial is a different concentration: 30 units at 5 mg/mL, 75 units at 2 mg/mL, or 150 units at 1 mg/mL.

Does Ozempic come in 1.5 mg doses?

The Ozempic pen has fixed dose options (0.25, 0.5, 1.0, and 2.0 mg). There's no 1.5 mg setting on the pen. Patients who want a 1.5 mg dose are typically on compounded semaglutide drawn from a vial.

How do I know my vial's concentration?

Read the vial label. Look for "X mg/mL" or "X mg / Y mL" (divide to get mg/mL). If only total milligrams appear, the concentration is in the pharmacy's dispensing instructions. Call the pharmacy if you can't find it.

Why does the unit count differ between pharmacies?

Different compounding pharmacies use different concentrations to fit their vial sizes and dispensing protocols. The same 1.5 mg dose can be 30 units at one pharmacy and 60 units at another. Always re-check concentration when you switch pharmacies.

What size syringe should I use for 1.5 mg?

For a 1.5 mg dose at 2.5 mg/mL (60 units volume), use a 1 mL (100-unit) U-100 insulin syringe. The 0.5 mL syringe doesn't have room for a 60-unit draw.

Can I round up if my dose falls between unit markings?

Rounding up by 1 unit usually has no clinical effect. Don't round up by more than 1 to 2 units without confirming with your provider. Rounding down is generally safer when you're unsure.

What if I draw too much?

Push the excess back into the vial. Don't inject extra "to be safe." If you've already injected an over-dose, monitor for nausea, vomiting, and abdominal pain. Call your provider if symptoms are severe.

Does the syringe gauge matter?

For subcutaneous injection of semaglutide, 30- or 31-gauge needles in 5/16-inch or 1/2-inch lengths are standard. Smaller-gauge needles (higher number) are thinner and less painful but slower to inject. Length matters for body composition: 1/2-inch may be needed in patients with more subcutaneous tissue.

How accurate are unit markings on insulin syringes?

ISO 8537 specifies a tolerance of plus-or-minus 5 percent on insulin syringe markings. For a 60-unit draw that's plus-or-minus 3 units, which is clinically irrelevant for semaglutide.

Can I split a 1.5 mg dose into two smaller injections?

Semaglutide's pharmacokinetic profile is designed for weekly dosing (half-life around 7 days). Splitting into smaller, more frequent doses isn't generally recommended without provider guidance.

What concentration should I ask for?

Most patients are best served by 2.5 mg/mL because the unit math is clean across the standard dose ladder. If you're at a high dose (2.4 mg), 5 mg/mL gives a smaller injection volume (48 units instead of 96), which is more comfortable.

Why does my vial say 5 mg but I'm supposed to take 1.5 mg?

Vials are sold in multi-dose sizes. A 5 mg vial at 2.5 mg/mL is 2 mL of solution, which contains roughly three 1.5 mg doses or six 0.5 mg doses. Each draw takes only a fraction of the vial.

Author / review note

Reviewed by the FormBlends Medical Team. References include the U.S. Pharmacopeia chapter on insulin syringes (USP <>), Patel et al., Annals of Pharmacotherapy, 2024 (compounded GLP-1 dosing errors), and the FDA Adverse Event Reporting System dataset accessed Q1 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.